[SPSETIA] QoQ TTM Result on 31-Jan-2012 [#1]

Stock
[SPSETIA] SP SETIA BHD
Announcement Date
22-Mar-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Oct-2012
Quarter
31-Jan-2012 [#1]
Profit Trend
QoQ- 3.65%
YoY- 23.32%
Quarter Report
Latest QR
Upcoming QR
SPSETIA's Result
SPSETIA's Financial Summary
View:
Show?
TTM Result
31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 CAGR
Revenue 2,526,595 2,396,338 2,325,615 2,205,169 2,232,473 2,157,105 1,988,538 17.22%
PBT 567,505 483,268 453,471 443,918 430,594 422,919 413,344 23.41%
Tax -179,877 -143,379 -122,534 -111,687 -108,163 -102,973 -96,679 50.98%
NP 387,628 339,889 330,937 332,231 322,431 319,946 316,665 14.36%
-
NP to SH 393,816 349,259 340,100 339,940 327,973 320,660 316,666 15.56%
-
Tax Rate 31.70% 29.67% 27.02% 25.16% 25.12% 24.35% 23.39% -
Total Cost 2,138,967 2,056,449 1,994,678 1,872,938 1,910,042 1,837,159 1,671,873 17.76%
-
Net Worth 4,027,164 3,854,241 3,733,416 3,543,333 3,363,160 3,206,827 2,957,782 22.72%
Dividend
31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 CAGR
Div 275,561 256,242 256,242 244,086 244,086 225,463 225,463 14.24%
Div Payout % 69.97% 73.37% 75.34% 71.80% 74.42% 70.31% 71.20% -
Equity
31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 CAGR
Net Worth 4,027,164 3,854,241 3,733,416 3,543,333 3,363,160 3,206,827 2,957,782 22.72%
NOSH 2,003,564 1,927,120 1,904,804 1,845,486 1,788,915 1,771,728 1,661,675 13.22%
Ratio Analysis
31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 CAGR
NP Margin 15.34% 14.18% 14.23% 15.07% 14.44% 14.83% 15.92% -
ROE 9.78% 9.06% 9.11% 9.59% 9.75% 10.00% 10.71% -
Per Share
31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 CAGR
RPS 126.10 124.35 122.09 119.49 124.79 121.75 119.67 3.53%
EPS 19.66 18.12 17.85 18.42 18.33 18.10 19.06 2.07%
DPS 13.75 13.30 13.45 13.23 13.64 12.73 13.57 0.87%
NAPS 2.01 2.00 1.96 1.92 1.88 1.81 1.78 8.39%
Adjusted Per Share Value based on latest NOSH - 1,845,486
31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 CAGR
RPS 53.06 50.33 48.84 46.31 46.89 45.30 41.76 17.22%
EPS 8.27 7.34 7.14 7.14 6.89 6.73 6.65 15.56%
DPS 5.79 5.38 5.38 5.13 5.13 4.74 4.74 14.20%
NAPS 0.8458 0.8095 0.7841 0.7442 0.7063 0.6735 0.6212 22.73%
Price Multiplier on Financial Quarter End Date
31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 CAGR
Date 31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 29/07/11 29/04/11 -
Price 3.61 3.63 3.62 3.95 3.84 3.90 4.18 -
P/RPS 2.86 2.92 2.96 3.31 3.08 3.20 3.49 -12.37%
P/EPS 18.37 20.03 20.27 21.44 20.95 21.55 21.93 -11.09%
EY 5.44 4.99 4.93 4.66 4.77 4.64 4.56 12.42%
DY 3.81 3.66 3.72 3.35 3.55 3.26 3.25 11.12%
P/NAPS 1.80 1.82 1.85 2.06 2.04 2.15 2.35 -16.21%
Price Multiplier on Announcement Date
31/10/12 31/07/12 30/04/12 31/01/12 31/10/11 31/07/11 30/04/11 CAGR
Date 12/12/12 13/09/12 21/06/12 22/03/12 08/12/11 22/09/11 09/06/11 -
Price 3.15 3.78 3.86 3.89 3.86 3.06 4.10 -
P/RPS 2.50 3.04 3.16 3.26 3.09 2.51 3.43 -18.93%
P/EPS 16.03 20.86 21.62 21.12 21.05 16.91 21.51 -17.72%
EY 6.24 4.79 4.63 4.74 4.75 5.91 4.65 21.55%
DY 4.37 3.52 3.49 3.40 3.53 4.16 3.31 20.24%
P/NAPS 1.57 1.89 1.97 2.03 2.05 1.69 2.30 -22.38%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment